Medical Stocks To Add to Your Watchlist - August 9th

Key Points

• The article highlights seven medical stocks to watch, including Eli Lilly, UnitedHealth Group, and Gilead Sciences, which show high trading volumes recently.
• Eli Lilly's stock has seen a significant drop of 14% post-earnings, prompting speculation about buying opportunities.
• UnitedHealth Group's shares traded up to $250.74 with steady market performance and a diversified health care service model.

Eli Lilly and Company, UnitedHealth Group, Tempus AI, Gilead Sciences, Vertex Pharmaceuticals, Johnson & Johnson, and Walmart are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies operating within the healthcare sector. They encompass businesses such as pharmaceutical and biotechnology firms, medical device manufacturers, hospital operators, and health-service providers. Investors buy and sell medical stocks to gain exposure to the industry’s growth potential, which is often driven by innovation, demographic trends, and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

NYSE LLY traded down $15.71 during trading hours on Friday, reaching $625.15. The company's stock had a trading volume of 14,089,857 shares, compared to its average volume of 4,833,475. The company's 50-day moving average is $774.10 and its two-hundred day moving average is $798.80. The stock has a market cap of $592.48 billion, a PE ratio of 40.86, a PEG ratio of 0.91 and a beta of 0.44. Eli Lilly and Company has a fifty-two week low of $623.78 and a fifty-two week high of $972.53. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.06 and a current ratio of 1.37.

Read Our Latest Research Report on LLY

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

NYSE UNH traded up $6.07 during mid-day trading on Friday, reaching $250.74. 10,146,688 shares of the stock were exchanged, compared to its average volume of 18,404,546. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The business's fifty day simple moving average is $291.78 and its 200 day simple moving average is $406.82. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $227.46 billion, a PE ratio of 10.86, a PEG ratio of 1.58 and a beta of 0.43.

Read Our Latest Research Report on UNH

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

TEM stock traded up $2.13 during midday trading on Friday, reaching $60.87. 26,073,235 shares of the company's stock traded hands, compared to its average volume of 8,255,315. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56. The company has a market capitalization of $10.54 billion, a P/E ratio of -7.80 and a beta of 4.98. The business has a 50-day moving average price of $62.47 and a two-hundred day moving average price of $58.00. Tempus AI has a fifty-two week low of $31.36 and a fifty-two week high of $91.45.

Read Our Latest Research Report on TEM

Gilead Sciences (GILD)

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.

Shares of NASDAQ GILD traded up $9.13 during trading on Friday, reaching $119.41. 13,112,190 shares of the stock were exchanged, compared to its average volume of 5,807,634. The company has a market capitalization of $148.54 billion, a price-to-earnings ratio of 23.79, a price-to-earnings-growth ratio of 0.70 and a beta of 0.33. The business's 50-day moving average price is $110.93 and its 200 day moving average price is $107.43. The company has a quick ratio of 1.23, a current ratio of 1.37 and a debt-to-equity ratio of 1.16. Gilead Sciences has a twelve month low of $72.43 and a twelve month high of $121.38.

Read Our Latest Research Report on GILD

Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.

VRTX stock traded down $9.09 during trading on Friday, reaching $366.54. The stock had a trading volume of 3,679,339 shares, compared to its average volume of 1,989,627. The firm has a fifty day moving average price of $450.77 and a 200 day moving average price of $465.51. Vertex Pharmaceuticals has a 1-year low of $364.66 and a 1-year high of $519.88. The company has a market capitalization of $93.98 billion, a P/E ratio of 26.20 and a beta of 0.44.

Read Our Latest Research Report on VRTX

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

JNJ traded up $1.87 during trading on Friday, hitting $173.40. The company had a trading volume of 7,686,049 shares, compared to its average volume of 9,496,232. The company has a market cap of $417.61 billion, a PE ratio of 18.55, a P/E/G ratio of 2.18 and a beta of 0.41. The business has a 50-day moving average of $159.26 and a 200-day moving average of $157.44. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $173.96.

Read Our Latest Research Report on JNJ

Walmart (WMT)

Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.

NYSE WMT traded up $0.65 on Friday, hitting $103.77. 12,392,140 shares of the stock traded hands, compared to its average volume of 14,088,264. The stock has a 50-day moving average of $97.30 and a 200 day moving average of $95.37. Walmart has a twelve month low of $67.14 and a twelve month high of $105.30. The company has a market capitalization of $828.13 billion, a P/E ratio of 44.35, a price-to-earnings-growth ratio of 4.96 and a beta of 0.66. The company has a current ratio of 0.78, a quick ratio of 0.22 and a debt-to-equity ratio of 0.47.

Read Our Latest Research Report on WMT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.